| CL02{1a14cab8ad40fbf5f482515b51373e445c09fe63c1b9eec56515ff021cdcb00e}2520RAH{1a14cab8ad40fbf5f482515b51373e445c09fe63c1b9eec56515ff021cdcb00e}2520FY2-GPST{1a14cab8ad40fbf5f482515b51373e445c09fe63c1b9eec56515ff021cdcb00e}2520Emergency{1a14cab8ad40fbf5f482515b51373e445c09fe63c1b9eec56515ff021cdcb00e}2520Medicine{1a14cab8ad40fbf5f482515b51373e445c09fe63c1b9eec56515ff021cdcb00e}2520August{1a14cab8ad40fbf5f482515b51373e445c09fe63c1b9eec56515ff021cdcb00e}25202024.docx?d=w00b2fd00b16744a9a50facbb68c5b57e&csf=1&web=1&e=9oZ1gz | |
